SCHEMBL7920063

SCHEMBL7920063

CC(=O)Nc1cccc2c1CCC1(CNC=N1)C2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
ALDH1A1 P00352 5/20 0.39
ADRA2A P08913 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
GAA P10253 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 1/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
TIPARP Q7Z3E1 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CASP3 P42574 1/20 0.34
PARP14 Q460N5 1/20 0.34
CHEK1 O14757 1/20 0.34
SLC18A3 Q16572 1/20 0.34
TUBB4A P04350 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7918401 0.81 NPC1 (0.41) NPC1RAB9AALDH1A1ADRA2AKDM4E
SCHEMBL7922107 0.81 NPC1 (0.41) NPC1RAB9AALDH1A1ADRA2AKDM4E
SCHEMBL7919151 0.77 NPC1 (0.40) NPC1RAB9AALDH1A1ADRA2AKDM4E
SCHEMBL7913137 0.76 NPC1 (0.37) NPC1RAB9AALDH1A1ADRA2AKDM4E
SCHEMBL7923192 0.74 ADRA2A (0.34) ADRA2A
SCHEMBL7916903 0.73 NPC1 (0.39) NPC1RAB9AALDH1A1ADRA2AKDM4E
SCHEMBL1011302 0.70 NPC1 (0.52) NPC1RAB9AALDH1A1ADRA2AKDM4E
SCHEMBL7918299 0.69 GRM5 (0.32)
SCHEMBL1638724 0.69 ALDH1A1 (0.72) NPC1RAB9AALDH1A1KDM4EHPGD
SCHEMBL30567324 0.69 ALDH1A1 (0.68) NPC1RAB9AALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010042475-A1 SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS SCHERING CORPORATION (US) 2010-04-15 WO disclosed